HLN.L vs PRGO
HLN.L: A leading global consumer healthcare business managing a portfolio of world-class brands in pain relief, oral health, and wellness. PRGO: Perrigo is a global provider of consumer self-care and over-the-counter health products designed to help individuals manage their personal health and wellness.
Side-by-side fundamentals
| Metric | HLN.L | PRGO | Edge |
|---|---|---|---|
| Price | £3.42 | $14.50 | |
| Market cap | $38.9B | $2.0B | |
| P/E FY to 2025-12-31, filed 2026-03-13 | 18.41 | n/a | |
| Net margin | +15.2% | -33.5% | HLN.L higher |
| Gross margin | +64.2% | +35.1% | HLN.L higher |
| Operating margin FY2025, SEC XBRL | n/a | -26.4% | |
| ROE | +10.2% | -48.6% | HLN.L higher |
| ROA FY2025, SEC XBRL | n/a | -16.7% | |
| Debt / equity as of 2026-09-02 | n/a | 1.31 | |
| Revenue growth (YoY) as of 2026-09-02 | n/a | -4.2% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -1.5% | |
| Dividend yield as of 2026-09-02 | n/a | +8.6% | |
| Dividend streak (yrs) SEC XBRL | n/a | 14 | |
| Beta as of 2026-09-02 | n/a | 0.85 | |
| 1-year return | +3.7% | -33.0% | HLN.L higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.